Suven Pharmaceuticals Ltd. - Research Center
543064 SUVENPHAR Group (A) BSE data
Add to watchlist
| Results | |
| Statement |
P&L
|
| More |
Profit loss account
(Rs crore)
| Mar ' 24 | Mar ' 23 | Mar ' 22 | Mar ' 21 | Mar ' 20 | |
|---|---|---|---|---|---|
| Income | |||||
| Operating income | 1,024.99 | 1,330.08 | 1,320.22 | 1,009.72 | 833.79 |
| Expenses | |||||
| Material consumed | 305.07 | 402.36 | 401.55 | 303.70 | 230.14 |
| Manufacturing expenses | 124.97 | 168.93 | 170.74 | 120.98 | 104.80 |
| Personnel expenses | 126.88 | 100.84 | 100.48 | 87.29 | 73.72 |
| Selling expenses | - | - | - | - | - |
| Adminstrative expenses | 58.17 | 74.87 | 67.46 | 57.23 | 39.98 |
| Expenses capitalised | - | - | - | - | - |
| Cost of sales | 615.09 | 747.00 | 740.23 | 569.20 | 448.64 |
| Operating profit | 409.90 | 583.08 | 579.99 | 440.52 | 385.15 |
| Other recurring income | 55.09 | 44.55 | 187.79 | 14.24 | 18.12 |
| Adjusted PBDIT | 464.99 | 627.63 | 767.78 | 454.76 | 403.26 |
| Financial expenses | 7.43 | 5.39 | 6.23 | 9.14 | 21.81 |
| Depreciation | 48.79 | 42.84 | 39.10 | 31.64 | 23.86 |
| Other write offs | - | - | - | - | - |
| Adjusted PBT | 408.77 | 579.39 | 722.45 | 413.98 | 357.59 |
| Tax charges | 103.96 | 146.79 | 164.35 | 105.33 | 87.51 |
| Adjusted PAT | 304.82 | 432.60 | 558.10 | 308.65 | 270.08 |
| Non recurring items | -0.30 | -0.35 | -0.76 | - | -0.82 |
| Other non cash adjustments | - | - | - | - | - |
| Reported net profit | 304.52 | 432.25 | 557.34 | 308.65 | 269.26 |
| Earnigs before appropriation | 1,794.59 | 1,708.64 | 1,393.21 | 877.17 | 660.25 |
| Equity dividend | - | 203.65 | 101.83 | 25.46 | 50.56 |
| Preference dividend | - | - | - | - | - |
| Dividend tax | - | - | - | - | 13.08 |
| Retained earnings | 1,794.59 | 1,504.99 | 1,291.39 | 851.71 | 596.60 |
© 2024 Rediff.com India Limited. All rights reserved. Disclaimer - Terms of Service - Privacy Policy - Feedback
DISCLAIMER: All financials are on standalone basis